Evidence map›Paper›PMID 33812378›Full record

Trial reportLipids in health and disease2021

Age and sex are associated with the plasma lipidome: findings from the GOLDN study.

Emily Slade, Marguerite R Irvin, Kevin Xie, Donna K Arnett, Steven A Claas, Tobias Kind, David W Fardo, Gregory A Graf

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Lipids in health and disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00083369 (Genetic and Environmental Determinants of Triglycerides), which is not on this map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00083369 completednot on this map

Genetic and Environmental Determinants of Triglycerides (GOLDN)

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2002 to 2009Enrolled1,327ConditionsAtherosclerosis, Cardiovascular Diseases, Heart Diseases
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Emily SladeDepartment of Biostatistics, University of Kentucky, 725 Rose St, Multidisciplinary Science Building, Suite 205, Lexington, KY, 40536, USA. Emily.Slade@uky.edu.ORCID http://orcid.org/0000-0002-1654-3822
Marguerite R IrvinDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Kevin XieDepartment of Biostatistics, University of Kentucky, 725 Rose St, Multidisciplinary Science Building, Suite 205, Lexington, KY, 40536, USA.
Donna K ArnettCollege of Public Health, University of Kentucky, Lexington, KY, USA.
Steven A ClaasCollege of Public Health, University of Kentucky, Lexington, KY, USA.
Tobias KindWest Coast Metabolomics Center, University of California, Davis, CA, USA.
David W FardoDepartment of Biostatistics, University of Kentucky, 725 Rose St, Multidisciplinary Science Building, Suite 205, Lexington, KY, 40536, USA.
Gregory A GrafDepartment of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, USA.
University of Kentucky · USUniversity of Alabama at Birmingham · USUniversity of California, Davis · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
Understanding the role of anti-apolipoprotein A-I antibodies in atherosclerotic cardiovascular diseaseP20GM130456 · NIGMS · UNIVERSITY OF KENTUCKY · PI M. Ashfaqul Alam · 2020 to 2026
$18.7M
The role of IKKß in linking obesity to adipose tissue inflammation and adipogeneP20GM103527 · NIGMS · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J · 2012 to 2017
$13.7M
Genetic and Environmental Determinants of TriglyceridesU01HL072524 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ARNETT, DONNA K · 2002 to 2008
$11.9M
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary FatR01HL091357 · NHLBI · UNIVERSITY OF KENTUCKY · PI ARNETT, DONNA K · 2008 to 2018
$5.8M
Pilot Projects ProgramP30GM127211 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2018 to 2022
$5.7M
Contributions of Hepatic and Intestinal Pathways to Cholesterol ExcretionR01DK113625 · NIDDK · UNIVERSITY OF KENTUCKY · PI Gregory A Graf · 2017 to 2026
$4.2M
The surprising impact of APOE alleles on gut microbiome: does altering the microbiome reduce AD risk?R56AG057589 · NIA · UNIVERSITY OF KENTUCKY · PI ESTUS, STEVEN · 2018 to 2018
$610k
American Heart Association 15SDG25760020NCATS NIH HHS UL1 TR001998NCATS NIH HHS UL1TR001998NHLBI NIH HHS R01 HL091357NHLBI NIH HHS R01HL091357NHLBI NIH HHS U01 HL072524NHLBI NIH HHS U01HL072524NIA NIH HHS R56 AG057589NIA NIH HHS R56AG057589NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R01 DK113625NIDDK NIH HHS R01DK113625NIGMS NIH HHS P20 GM103527NIGMS NIH HHS P20 GM130456NIGMS NIH HHS P20GM130456NIGMS NIH HHS P30 GM127211
6 · The paper itself

Abstract

backgroundDeveloping an understanding of the biochemistry of aging in both sexes is critical for managing disease throughout the lifespan. Lipidomic associations with age and sex have been reported, but prior studies are limited by measurements in serum rather than plasma or by participants taking lipid-lowering medications.

methodsOur study included lipidomic data from 980 participants aged 18-87 years old from the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN). Participants were off lipid-lowering medications for at least 4 weeks, and signal intensities of 413 known lipid species were measured in plasma. We examined linear age and sex associations with signal intensity of (a) 413 lipid species; (b) 6 lipid classes (glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, fatty acids, and acylcarnitines); and (c) 15 lipid subclasses; as well as with the particle sizes of three lipoproteins.

resultsSignificant age associations were identified in 4 classes, 11 subclasses, 147 species, and particle size of one lipoprotein while significant sex differences were identified in 5 classes, 12 subclasses, 248 species, and particle sizes of two lipoproteins. For many lipid species (n = 97), age-related associations were significantly different between males and females. Age*sex interaction effects were most prevalent among phosphatidylcholines, sphingomyelins, and triglycerides.

conclusionWe identified several lipid species, subclasses, and classes that differ by age and sex; these lipid phenotypes may serve as useful biomarkers for lipid changes and associated cardiovascular risk with aging in the future. Future studies of age-related changes throughout the adult lifespan of both sexes are warranted.

trial registrationClinicalTrials.gov NCT00083369 ; May 21, 2004.

Indexed as

LipidomicsSex CharacteristicsAdolescentAdultAgedAged, 80 and overAge FactorsFemaleHumansLipidsLipoproteinsMaleMiddle AgedParticle SizeYoung AdultLipidsLipoproteinsAcylcarnitinesAgeCohortFatty acidGlycerolipidsGlycerophospholipidsLipidomicsSexSphingomyelinSterols

Identifiers

PMID33812378
PMCPMC8019182
OpenAlexW3147911425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.